J.P. Morgan has upgraded Amneal Pharmaceuticals, Inc (NASDAQ:AMRX), noting the company’s generics business is increasingly ...

The generic drug was launched in September. J.P. Morgan analyst Chris Schott reports that Crexont prescriptions are nearing 1,000 per week, with 964 recorded in the week of February 14.

The country’s only manufacturer of generic abortion medication asked to be a part of the first legal fight over the procedure ...

Indian pharmaceutical industry leaders indicate that proposed US tariffs on pharmaceutical exports may lead to increased drug ...

The maker of Reynolds Wrap aluminum foil must face a proposed class action claiming it misled consumers who wanted to "buy ...

First, shoppers squeezed by inflation began ditching name-brand snacks and drinks in favor of lower-price store brands. But ...

The company's focus on generic drugs, biosimilars, and specialty pharmaceuticals has garnered attention from analysts who see potential for sustained expansion. This comprehensive analysis ...

The manufacturer of generic mifepristone, GenBioPro told the U.S. District Court for the Northern District of Texas Tuesday that it wants to “ensure that its rights are fully and adequately ...

A study co-authored by an Indiana University researcher found that generic drugs made in India—the source for most imported ...